The diagnosis and management of anterior scleritis

International Ophthalmology Clinics

Volumn 45, Issue 2, 2005, Pages 191-204

  Albini, Thomas A ^a   Rao, Narsing A ^a   Smith, Ronald E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMPHENICOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIFLUNISAL; IBUPROFEN; INDOMETACIN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISONE; SULINDAC; TOBRAMYCIN; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ALOPECIA; AZOOSPERMIA; BONE MARROW SUPPRESSION; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EPISCLERITIS; GASTROINTESTINAL SYMPTOM; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTRAOCULAR HYPERTENSION; IRIDOCYCLITIS; IRITIS; LABORATORY TEST; LEUKOPENIA; LYMPHOMA; MENTAL DISEASE; MYELODYSPLASIA; NAUSEA AND VOMITING; NECROSIS; OSTEOPOROSIS; OVARY DISEASE; PATHOGENESIS; PERFORATION; PRIORITY JOURNAL; REVIEW; SCLERA DISEASE; SCLERITIS; SEROLOGY; SIDE EFFECT; TESTIS ATROPHY; THORAX RADIOGRAPHY;

ANTERIOR EYE SEGMENT; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EYE DISEASES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SCLERITIS;

EID: 17644391729     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000155900.64809.b2     Document Type: Review

References (43)

1. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163-191.
2. Watson PG. Treatment of scleritis and episcleritis. Trans Ophthalmol Soc UK. 1974;94:76-79.
3. Watson PG, Hazelman BL. The Sclera and Systemic Disorders. Philadelphia, PA; W.B. Saunders; 1976.
4. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467-471.
5. Smith RE, Nozick RA. Uveitis: A Clinical Approach to Diagnosis and Management. Baltimore, MD: Williams & Wilkins; 1989.
6. Foster CS. Immunologic disorders of the conjunctiva, cornea, and sclera. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, PA: W.B. Saunders; 2000:803-829.
7. Watson PG. The diagnosis and management of scleritis. Ophthalmology. 1980;87:716-720.
8. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687-692.
9. Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol. 2001;12:471-478.
10. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101:1281-1286.
11. McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192-226.
12. Power WJ, Rodriguez A, Neves RA, et al. Disease relapse in patients with ocular manifestations of Wegener granulomatosis. Ophthalmology. 1995;102:154-160.
13. Rucker CW, Ferguson RH. Ocular manifestations of relapsing polychondritis. Arch Ophthalmol. 1965;73:46-48.
14. Hoang-Xaun T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology. 1990;97:892-898.
15. Loeffler KU, McLean IW. Bilateral necrotizing scleritis and blindness in the myelodysplastic syndrome presumably due to relapsing polychondritis. Acta Ophthalmol Scand. 2000;78:228-231.
16. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol. 2001;131:451-456.
17. Zierhut M, Schlote T, Stubiger N, et al. Cogan I syndrome: clinical aspects, therapy and prognosis. Ophthalmologe. 2000;97:197-202.
18. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100:1775-1781.
19. Jain R, Ionides A, Pavesio C, et al. Scleritis as a presenting feature of Takayasu's disease. Br J Ophthalmol. 2000;84:801.
20. Smith JR, Rosenbaurn JT. Case reports and small case series: scleritis occurring in association with Takayasu's disease. Arch Ophthalmol. 2001;119:778-779.
21. Cury D, Breakey AS, Payne BF. Allergic granulomatosis angiitis associated with uveoscleritis and papilledema. AMA Arch Ophthalmol. 1956;55:261-266.
22. Sainz de la Maza M, Hemady RK, Foster CS. Infectious scleritis: report of four cases. Doc Ophthalmol. 1993;83:33-41.
23. Reynolds MG, Alfonso E. Treatment of infectious scleritis and keratoscleritis. Am J Ophthalmol. 1991;112:543-547.
24. Zamir E, Read RW, Rao NA. Self-inflicted anterior scleritis. Ophthalmology. 2001;108:192-195.
25. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328-1333.
26. Soukiasian SH, Foster CS, Niles JL, et al. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology. 1992;99:125-132.
27. Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501-506.
28. Barr CC, Davis H, Culbertson WW. Rheumatoid scleritis. Ophthalmology. 1981;88:1269-1273.
29. Nieuwenhuizen J, Watson PG, Emmanouilidis-van der Spek K, et al. The value of combining anterior segment fluorescein angiography with indocyanine green angiography in scierai inflammation. Ophthalmology. 2003;110:1653-1666.
30. Heiligenhaus A, Schilling M, Lung E, et al. Ultrasound biomicroscopy in scleritis. Ophthalmology. 1998;105:527-534.
31. Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469-476.
32. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
33. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252-257.
34. McMullen M, Kovarik G, Hodge WG. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis. Can J Ophthalmol. 1999;34:217-221.
35. Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology. 1993;100:1372-1376.
36. Zamir E, Read RW, Smith RE, et al. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology. 2002;109:798-805.
37. Jabs DA. Discussion. Ophthalmology. 2002;109:806-807.
38. Tu EY, Culbertson WW, Pflugfelder SC, et al. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995;102:718-724.
39. Croasdale CR, Brightbill FS. Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis. Arch Ophthalmol. 1999;117:966-968.
40. Hessburg PC. Pseudomonas corneoscleral ulcers. Am J Ophthalmol. 1982;93:256-257.
41. Nguyen QD, Foster CS. Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin. 1999;39:109-131.
42. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389-396.
43. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis-associated uveitis. Ophthalmology. 1997;104:58-63.